KNSA — Kiniksa Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual balance sheet for Kiniksa Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	233	323	182	191	206
Net Total Accounts Receivable
Net Total Receivables	—	—	3.98	20.3	21.3
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	242	333	196	243	276
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	8.32	10.6	8.38	7.04	12.7
Net Intangible Assets
Other Long Term Assets
Total Assets	255	349	233	460	526
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	27.8	31.8	44.8	47.1	63.7
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	29.1	37.5	47.8	63.5	87.5
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	225	312	185	396	439
Total Liabilities & Shareholders' Equity	255	349	233	460	526
Total Common Shares Outstanding